MGH Center for Women's Mental Health

About MGH Center for Women's Mental Health

This author has not yet filled in any details.
So far MGH Center for Women's Mental Health has created 1461 blog entries.

Maternal Adverse Childhood Experiences Linked to Changes in Neonatal Brain Development and Behavior

Maternal ACEs were associated with both newborn amygdala volume and subsequent infant negative emotionality.

By |2022-09-29T13:57:02-04:00October 4th, 2022|Child Outcomes, Psychiatric Disorders During Pregnancy, PTSD and Stress Related Disorders|Comments Off on Maternal Adverse Childhood Experiences Linked to Changes in Neonatal Brain Development and Behavior

Postpartum psychosis: Does longitudinal course inform treatment?

Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on clinical issues regarding prescribing antidepressants during pregnancy with Ob.Gyn News on August 16, [...]

By |2022-10-03T09:59:55-04:00October 3rd, 2022|Postpartum Psychiatric Disorders, Postpartum Psychosis, Treatment|Comments Off on Postpartum psychosis: Does longitudinal course inform treatment?

How Common Are Obsessive-Compulsive Related Disorders in Pregnant and Postpartum Women?

A recent study shows the OCRDs, especially those that are more body-focused, have the potential to emerge or worsen during pregnancy and the postpartum, leading to high levels of comorbid depression and functional impairment.

By |2022-09-27T10:23:29-04:00September 28th, 2022|Postpartum Psychiatric Disorders, Psychiatric Disorders During Pregnancy|Comments Off on How Common Are Obsessive-Compulsive Related Disorders in Pregnant and Postpartum Women?

Risk of Neonatal Opioid Withdrawal Syndrome More Common with Certain Opioids: Implications for Women with Opioid Use Disorder

More infants who were exposed to strong agonists and opioids with long half-lives, including methadone, developed neonatal opioid withdrawal syndrome.

By |2022-09-27T09:13:32-04:00September 27th, 2022|Opioids, Perinatal Substance Use, Prevalence & Risk Factors|Comments Off on Risk of Neonatal Opioid Withdrawal Syndrome More Common with Certain Opioids: Implications for Women with Opioid Use Disorder

FDA Accepts New Drug Application for Fezolinetant, A Novel Nonhormonal Treatment for Vasomotor Symptoms

The FDA accepted a New Drug Application for fezolinetant, a novel, nonhormonal selective neurokinin-3 receptor (NK3R) antagonist for the treatment of menopause-related vasomotor symptoms.

By |2022-08-29T14:26:08-04:00August 26th, 2022|Medication, Menopausal Symptoms, Treatment, Vasomotor Symptoms|Comments Off on FDA Accepts New Drug Application for Fezolinetant, A Novel Nonhormonal Treatment for Vasomotor Symptoms

Essential Reads: Folic Acid, Neural Tube Defects, and Congenital Heart Defects

Despite the unequivocal benefits of folic acid supplementation and recommendations urging all women of reproductive age to take folic acid supplements, preconceptual use of folic acid has not increased substantially.

By |2022-08-29T14:34:36-04:00August 24th, 2022|Alternative & Complementary, Essential Reads, Outcomes, Psychiatric Disorders During Pregnancy, Risk of Malformations|Comments Off on Essential Reads: Folic Acid, Neural Tube Defects, and Congenital Heart Defects
Go to Top